A full list of the contents of the latest issue of Pharma.
Read the full PDF
Optometry Australia revises guidelines for diabetic retinopathy
Pharmacology: systemic treatment for ocular disease
Dr Alex Hui
Ultra-wide field imaging and diabetic retinopathy
Treating CSCR with oral eplerenone
Should optometrists recommend fenofibrate?
Vincent Khou, Paula Katalinic and Dr Barbara Zangerl / Centre for Eye Health
Chair-side Reference: Retinal Vascular Disease
Christina Ly / Centre for Eye Health
CXO featured article:
Quantitative evaluation of early retinal changes in children with type 1 diabetes mellitus without retinopathy
Kemal Tekin, Merve Inanc, Erdal Kurnaz, Elvan Bayramoglu, Emre Aydemir, Mustafa Koc, Hasan Kiziltoprak, Zehra Aycan
OCT-A vs FA
Dr Graham Lakkis
Automatic for the people?
Dr A. Paul Chous
Pharma online CPD module (6 3T)
Published by Optometry Australia ABN 17 004 622 431. Suite 101, 70 York Street, South Melbourne VIC 3205.
Editor: JEFF MEGAHAN
Phone 03 9668 8500, firstname.lastname@example.org, www.optometry.org.au
Interim Clinical Editorial Panel
SOPHIE KOH BOptom, GradCertOcTher, LmusTCL
ANDREW KOTSOS BOptom, PGCertOcTher
Business Development Manager: LEANNE DAWSON
Publications Manager: JESSICA DONALD
Cover: LACHLAN HESSING, image by Michele Tardivo on Unsplash
Copyright © 2018
Comments made in Pharma are of a general nature and intended for guidance only. Optometry Australia and the individual contributors expressly disclaim all liability and responsibility to any person in respect of, and for the consequences of, anything done or omitted to be done in reliance wholly or partly on anything in this publication.
Pharma is distributed in Australia and New Zealand. All references to pharmaceutical preparations in Pharma are applicable within Australia.